167 related articles for article (PubMed ID: 38509882)
1. The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug-drug interaction for comorbid COVID-19 patients.
Nguyen TK; Vu GM; Duong VC; Pham TL; Nguyen NT; Tran TTH; Tran MH; Nguyen DT; Vo NS; Phung HT; Hoang TH
Heliyon; 2024 Mar; 10(6):e27043. PubMed ID: 38509882
[TBL] [Abstract][Full Text] [Related]
2. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude.
Wang LY; Cui JJ; OuYang QY; Zhan Y; Wang YM; Xu XY; Yu LL; Yin H; Wang Y; Luo CH; Guo CX; Yin JY
EPMA J; 2021 Sep; 12(3):307-324. PubMed ID: 34306260
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
Sahana S; Sivadas A; Mangla M; Jain A; Bhoyar RC; Pandhare K; Mishra A; Sharma D; Imran M; Senthivel V; Divakar MK; Rophina M; Jolly B; Batra A; Sharma S; Siwach S; Jadhao AG; Palande NV; Jha GN; Ashrafi N; Mishra PK; Vidhya AK; Jain S; Dash D; Kumar NS; Vanlallawma A; Sarma RJ; Chhakchhuak L; Kalyanaraman S; Mahadevan R; Kandasamy S; Devi P; Rajagopal RE; Ramya JE; Devi PN; Bajaj A; Gupta V; Mathew S; Goswami S; Prakash S; Joshi K; Kumla M; Sreedevi S; Gajjar D; Soraisham R; Yadav R; Devi YS; Gupta A; Mukerji M; Ramalingam S; Binukumar BK; Sivasubbu S; Scaria V
Pharmacogenomics; 2021 Jul; 22(10):603-618. PubMed ID: 34142560
[No Abstract] [Full Text] [Related]
5. A study of genetic variants associated with skin traits in the Vietnamese population.
Hoang TH; Vu DM; Vu GM; Nguyen TK; Do NM; Duong VC; Pham TL; Tran MH; Khanh Nguyen LT; Han HTT; Can TT; Pham TH; Pham TD; Nguyen TH; Do HP; Vo NS; Nguyen XH
BMC Genomics; 2024 Jan; 25(1):52. PubMed ID: 38212682
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
7. Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.
Thomas L; Birangal SR; Ray R; Sekhar Miraj S; Munisamy M; Varma M; S V CS; Banerjee M; Shenoy GG; Rao M
Ther Adv Drug Saf; 2021; 12():20420986211041277. PubMed ID: 34471515
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.
Stanković B; Kotur N; Gašić V; Klaassen K; Ristivojević B; Stojiljković M; Pavlović S; Zukić B
J Med Biochem; 2020 Oct; 39(4):488-499. PubMed ID: 33312066
[TBL] [Abstract][Full Text] [Related]
9. A Vietnamese human genetic variation database.
Le VS; Tran KT; Bui HTP; Le HTT; Nguyen CD; Do DH; Ly HTT; Pham LTD; Dao LTM; Nguyen LT
Hum Mutat; 2019 Oct; 40(10):1664-1675. PubMed ID: 31180159
[TBL] [Abstract][Full Text] [Related]
10. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.
Bertholim-Nasciben L; Scliar MO; Debortoli G; Thiruvahindrapuram B; Scherer SW; Duarte YAO; Zatz M; Suarez-Kurtz G; Parra EJ; Naslavsky MS
Front Pharmacol; 2023; 14():1178715. PubMed ID: 37234706
[No Abstract] [Full Text] [Related]
12. Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
[TBL] [Abstract][Full Text] [Related]
13. Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.
Mbavha BT; Kanji CR; Stadler N; Stingl J; Stanglmair A; Scholl C; Wekwete W; Masimirembwa C
Pharmacogenet Genomics; 2022 Jul; 32(5):173-182. PubMed ID: 35190514
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir.
Quah KSE; Huang X; Renia L; Oon HH
Ann Acad Med Singap; 2022 Dec; 51(12):774-786. PubMed ID: 36592146
[TBL] [Abstract][Full Text] [Related]
15. Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir.
Gerhart J; Draica F; Benigno M; Atkinson J; Reimbaeva M; Francis D; Baillon-Plot N; Sidhu GS; Damle BD
AAPS J; 2023 Jul; 25(5):73. PubMed ID: 37468770
[TBL] [Abstract][Full Text] [Related]
16. Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India.
Manjhi PK; Kumar R; Priya A; Rab I
Maedica (Bucur); 2021 Jun; 16(2):163-169. PubMed ID: 34621334
[No Abstract] [Full Text] [Related]
17. Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
Parada-Márquez JF; Maldonado-Rodriguez ND; Triana-Fonseca P; Contreras-Bravo NC; Calderón-Ospina CA; Restrepo CM; Morel A; Ortega-Recalde OJ; Silgado-Guzmán DF; Angulo-Aguado M; Fonseca-Mendoza DJ
Front Pharmacol; 2023; 14():1047854. PubMed ID: 37021041
[No Abstract] [Full Text] [Related]
18. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
19. Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review.
Conti V; Sellitto C; Torsiello M; Manzo V; De Bellis E; Stefanelli B; Bertini N; Costantino M; Maci C; Raschi E; Sabbatino F; Corbi G; Pagliano P; Filippelli A
JAMA Netw Open; 2022 Apr; 5(4):e227970. PubMed ID: 35438752
[TBL] [Abstract][Full Text] [Related]
20. Genetic landscape of recessive diseases in the Vietnamese population from large-scale clinical exome sequencing.
Tran NH; Nguyen Thi TH; Tang HS; Hoang LP; Nguyen TL; Tran NT; Trinh TN; Nguyen VT; Nguyen BH; Nguyen HT; Doan LP; Phan NM; Nguyen KT; Nguyen HL; Quach MT; Nguyen TT; Tran VU; Tran DV; Nguyen QT; Do TT; Lam NV; Cao Thi Ngoc P; Truong DK; Nguyen HN; Phan MD; Giang H
Hum Mutat; 2021 Oct; 42(10):1229-1238. PubMed ID: 34233069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
